|
|
Article: DEMOCRATS: HATCH-WAXMAN ACT EXPLOITED BY PHARMA INDUSTRY.(patent law loopholes benefit pharmaceutical companies)(Brief Article)
- Article from:
- BIOWORLD Today
- Article date:
- July 17, 2002
- Author:
CopyrightCOPYRIGHT 2002 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON - Senate Democrats have biotechnology and pharmaceutical lobbyists scrambling to preserve all elements of the 18-year-old law that created the generic drug industry.
Instead of debating Medicare legislation to provide prescription drug coverage for the elderly in the last few months before the mid-term elections, the Senate is looking at poking holes in the Hatch-Waxman Act of 1984.
"There has been an unrelenting, distorted and steady drumbeat of criticism aimed at the research-based pharmaceutical and biotechnology industry for the last several months - and now it has taken its toll," Jeff Trewhitt, spokesman for the Washington-based ...
Related newspaper, magazine, and journal articles:
|
|
Article: MEGABIOS, GENEMEDICINE AGREE TO `STRATEGIC MERGER' THAT POOLS ...
BIOWORLD Today;
October 27, 1998 ;
700+ words
... ... percent, or $0.281. McGraw told BioWorld Today the move is one of the few "strategic ... into GeneMedicine," Weintraub told BioWorld Today. "This merger allows us to simplify ... up relatively early," Waldron told BioWorld Today. "This merger announcement is the ...
|
|